Experience with quinupristin/dalfopristin in treating infections with vancomycin-resistant Enterococcus faecium in children

Pediatric Infectious Disease Journal

Volumn 19, Issue 3, 2000, Pages 234-238

  Gray, James W ^a   Darbyshire, Philip J ^a   Beath, Susan V ^a   Kelly, Deirdre ^a   Mann, Jillian R ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Enterococcus faecium; Quinupristin dalfopristin; Vancomycin resistant

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN;

ADOLESCENT; ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; ENTEROCOCCUS FAECIUM; FEMALE; HUMAN; INFANT; MALE; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; MALE; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE; VIRGINIAMYCIN;

EID: 0034023131     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200003000-00012     Document Type: Article

References (20)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;5:428-42.
2. Fuller RE, Drew RH, Perfect JR. Treatment of vancomycin-resistant enterococci, with a focus on quinupristin-dalfopristin. Pharmacotherapy 1996;16:584-92.
3. Griswold MW, Lomaestro BM, Briceland LL. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination. Am J Health-Syst Pharm 1996;53:2045-53.
4. Cassell J, Balakrishnan I, Samarasinghe D, Mistry P, Prentice HG, Gillespie SH. RP59500 (quinupristin/dalfopristin): three case reports of its use in infection due to Enterococcus faecium. J Infect 1998;36:324-7.
5. Dever LL, Smith SM, Dejesus D, et al. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/ dalfopristin): a report of fifteen cases. Microb Drug Resist 1996;2:407-13.
6. Lai KK. Treatment of vancomycin-resistant Enterococcus faecium infections. Arch Intern Med 1996;156:2579-84.
7. Linden P, Pasculle AW, Riddler S, Kusne S, Silverman A, Dean J. Quinupristin-dalfopristin (RP 59500) for the treatment of serious infection due to high level vancomycin-resistant Enterococcus faecium (VREF). In: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4 to 7, 1994. Washington, DC: American Society for Microbiology, 1994.
8. Linden PK, Pasculle AW, McDevitt D, Kramer DJ. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort. J Antimicrob Chemother 1997;39(Suppl A):1:45-51.
9. Sahgal VS, Urban C, Mariano N, Weinbaum F, Turner J, Rahal JJ. Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report. Microb Drug Resist 1995;1:245-7.
10. Gransden WR, King A, Marossy D, Rosenthal E. Quinupristin/dalfopristin in neonatal Enterococcus faecium meningitis. Arch Dis Child 1998;78:F235-6.
11. Nachman SA, Verma R, Egnor M. Vancomycin-resistant Enterococcus faecium infection in an infant: an antibiotic cure. Microb Drug Resist 1995;1:95-6.
12. Collee JG, Duguid JP, Fraser AG, Marmion BP, eds. Mackie & McCartney. Practical medical microbiology. 13th ed. Edinburgh: Churchill Livingstone, 1989.
13. Garner JS, Jarvis WR, Emori TG, Koran TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;1999;16:128-40.
14. Sánchez A, López-Herie J, Cueto E, Carrillo A, Moral R. Teicoplanin pharmacokinetics in critically ill paediatric patients. J Antimicrob Chemother 1999;44:407-9.
15. Williams JD, Maskell JP, Sefton AM. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. J Antimicrob Chemother 1997;39(Suppl A):41-6.
16. Das I, Gray J. Enterococcal bacteremia in children: a review of seventy-five episodes in a pediatric hospital. Pediatr Infect Dis J 1998;17:1154-8.
17. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23: 1234-9.
18. Mainous MR, Lipsett PA, O'Brien M. Enterococcal bacteremia in the surgical intensive care unit: does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group. Arch Surg 1997;132:76-81.
19. Hayden MK, Trenholme GM, Schultz JE, Sahm DF. In vivo development of teicoplanin resistance in a Van B Enterococcus faecium isolate. J Infect Dis 1993;167:1224-7.
20. Low DE. Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience. Microb Drug Resist 1995;1:223-34.